靜脈輸液治療與靜脈通路：全球市場

全球靜脈輸液（IV）療法和靜脈通路市場預計將從 2026 年的 495 億美元成長到 2031 年底的 676 億美元，在 2026 年至 2031 年的預測期內，複合年成長率將達到 6.4%。

本報告範圍

本報告分析了全球靜脈輸液（IV）療法和靜脈通路市場，全面概述了其在各種醫療保健環境中的應用。

本研究涵蓋了用於治療的各種靜脈輸液和輸液裝置。 BCC Research 分析了關鍵市場組成部分，包括靜脈輸液的類型。本報告按產品類型和應用領域進行了細分。依產品類型分類，市場分為靜脈輸液和輸液器、輸液幫浦及配件以及靜脈通路裝置（輸液導管）。靜脈輸液和輸液器進一步細分為通用靜脈輸液、腸外營養靜脈輸液、預拌藥物靜脈輸液以及其他靜脈輸液和輸液器。輸液幫浦及配件包括通用輸液幫浦、專用輸液幫浦和其他輸液配件。靜脈通路裝置包括周邊靜脈導管和中央靜脈導管。

每套靜脈輸液產品及其市場區隔：

• 一般靜脈輸液包括生理食鹽水、乳酸林格氏液、聚葡萄糖和水溶性葡萄糖，用於補液、液體補充和電解質管理。
• 腸外營養液包括含有碳水化合物、脂肪乳劑、胺基酸、維生素、礦物質和微量元素的靜脈營養製劑。
• 預配製靜脈輸液：這些輸液包含靜脈注射藥物，例如抗生素、止痛藥和心血管藥物，可直接使用，並以輸液袋、輸液瓶或其他容器包裝。
• 其他靜脈輸液和輸液器：除上述未列出的特殊靜脈輸液外，還包括輸液器、延長輸液器、連接器、過濾器和其他靜脈輸液配件。

本報告涵蓋靜脈輸液治療領域的創新、技術進步（專利和批准）以及監管方面的內容，例如最新趨勢、偏好和發展動態。報告中還包括全球靜脈輸液治療和靜脈通路市場的市場預測、主要參與者和市場佔有率分析。此外，報告範圍涵蓋了新興技術，例如先進的骨內注射系統、抗菌塗層輸液器、無針連接器、智慧靜脈可視化技術和靜脈通路裝置，這些技術有望提高血管通路手術的安全性、效率和可靠性。市場按主要區域分類，包括北美、亞太、歐洲和世界其他地區（RoW）。分析的國家包括美國、加拿大、墨西哥、法國、德國、英國、義大利、西班牙、日本、印度、澳洲、韓國和中國。

本報告內容

• 資料表 77 及補充表 68
• 全球靜脈輸液（IV）治療與靜脈通路市場概覽
• 全球趨勢分析，包括 2023-2025 年的銷售數據、2026 年的估計值以及到 2031 年的複合年成長率預測。
• 按產品類型、應用和地區進行市場評估。
• 對影響全球靜脈輸液療法和靜脈通路技術應用的關鍵市場促進因素、限制、挑戰和機會進行分析。
• 除了檢視主要國家的法規結構外，該分析還包括宏觀經濟因素、波特五力模型以及美國關稅對該產業的影響。
• 目標區域：北美、歐洲、亞太、中東和非洲、南美
• 對領先企業和新興創業公司進行介紹，包括 BD、費森尤斯集團、百特、貝朗集團和英舒樂集團，重點介紹每家公司的產品線、商業策略和最新發展。

目錄

第1章執行摘要

第2章 市場概覽

• 靜脈輸液療法概述
• 人體循環系統
• 液體療法的定義
• 靜脈輸液療法的定義
• 靜脈輸液的類型
• 持續輸注
• 間歇輸注
• 患者自控式液體管理
• 使用靜脈輸液幫浦進行給藥的方法
• 幫浦式輸液
• 靜脈注射
• 靜脈輸液
• 一般靜脈輸液
• 腸外營養：靜脈輸液
• 預先配製的靜脈注射藥物
• 靜脈輸液幫浦
• 靜脈通路裝置（靜脈導管）
• 波特五力分析靜脈輸液和靜脈通路市場
• 競爭公司之間的競爭
• 新進入者的威脅（低）
• 宏觀經濟因素分析
• 通貨膨脹和製造成本上升
• 美國-以色列-伊朗衝突對靜脈輸液（IV）療法和靜脈通路市場的影響。
• 全球經濟成長放緩和資本投資下降
• 政府醫療保健支出和醫療設備的本地化

第3章 市場動態

• 概述
• 市場促進因素
• 需要長期靜脈輸液治療的慢性疾病負擔日益惡化。
• 手術量和住院人數的增加推動了對血管通路的需求。
• 家庭靜脈輸液療法的快速發展
• 加強感染預防指引正在加速先進靜脈通路技術的應用。
• 全球靜脈血栓栓塞症(VTE) 和院內感染的負擔日益加重，推動了對先進靜脈輸液療法和靜脈通路解決方案的需求。
• 世界老年人口正在成長。
• 市場限制因素
• 感染疾病和併發症的風險
• 靜脈注射和靜脈通路市場面臨的監管挑戰
• 靜脈輸液治療中的安全性與召回挑戰
• 贖回政策
• 市場機遇
• 技術進步
• 擴大靜脈注射生物製藥和特殊療法的研發管線

第4章 監管情勢

• 當前法規狀況
• 美國
• 歐洲
• 日本
• 印度
• 中國
• 英國

第5章：新趨勢與技術

• 血管通路骨內注射系統的進展
• 抗菌塗層的醫療包
• 無針頭連接器
• 靜脈濾器
• 智慧靜脈可視化和穿刺裝置
• 智慧型靜脈輸液裝置
• 輸血包
• 無線感測網路（WSN）和人工智慧在靜脈輸液治療的應用
• 靜脈輸液治療和靜脈通路的最新進展
• 專利分析
• 主要發現

第6章 市場區隔分析

• 細分市場
• 市場分析：依產品類型
• 靜脈輸液和輸液器
• 點滴幫浦及配件
• 靜脈通路裝置（靜脈導管）
• 市場分析：按應用領域
• 醫院
• 備選候選地點
• 居家型
• 按地區分類
• 市場分析：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區

第7章 競爭情勢

• 行業概覽
• 主要公司的全球市場佔有率
• 獲得
• 策略聯盟

第8章附錄

• 調查方法
• 資訊來源
• 簡稱
• 公司簡介
• ANGIODYNAMICS
• BAXTER
• B. BRAUN SE
• BD
• CARDINAL HEALTH
• COOK MEDICAL INC.
• FRESENIUS SE & CO. KGAA
• ICU MEDICAL INC.
• INSULET CORP.
• IRADIMED CORP.
• MEDTRONIC
• PFIZER INC.
• TERUMO CORP.
• VYGON
• WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.
• 新興創業公司/市場顛覆者

The global market for intravenous (IV) therapy and vein access is expected to grow from $49.5 billion in 2026 and is projected to reach $67.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2026 to 2031.

Report Scope

This report examines the global IV therapy and vein access device market, providing a comprehensive review of applications across various healthcare facility settings.

The study covers a range of IV solutions and devices used in therapeutic applications. BCC Research has analyzed critical market components, including types of intravenous solutions. The report includes segments by product type and application. By product type, the market is segmented into IV solutions and sets, infusion pumps and accessories, and vein access devices (IV catheters). IV solutions and sets are categorized into general IV solutions, parenteral nutrition IV solutions, premixed drug IV solutions, and other IV solutions and sets. Infusion pumps and accessories include general infusion pumps, specialized infusion pumps, and other infusion accessories. Vein access devices cover peripheral intravenous catheters and central venous catheters.

Product inclusions for each IV solution and sets market segment:

• General IV solutions: Includes normal saline, hypertonic saline, Lactated Ringer's, Dextran, and dextrose in water used for hydration, fluid replacement, and electrolyte management.
• Parenteral nutrition IV solutions: Includes intravenous nutritional formulations containing carbohydrates, lipid emulsions, amino acids, vitamins, minerals, and trace elements.
• Premixed IV solutions: Includes ready-to-administer premixed IV drugs such as antibiotics, pain-management medications, and cardiovascular agents, supplied in IV bags, bottles, or other containers.
• Other IV solutions and sets: Includes specialized IV solutions not covered above, along with administration sets, extension sets, connectors, filters, and other IV delivery accessories.

This report addresses regulatory aspects, including innovations, technological advances (patents and approvals), and the latest trends, preferences, and developments in IV therapy. It also includes market projections, key companies, and market share analysis for the global IV therapy and vein access market. The scope also includes emerging technologies, such as advanced intraosseous infusion systems, antimicrobial-coated sets, needleless connectors, and smart vein visualization and vascular-access devices, which are expected to improve the safety, efficiency, and reliability of vascular-access procedures. The market has been segmented into major regions, including North America, Asia-Pacific, Europe, and the rest of the world (RoW). The analysis covers countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea, and China.

Report Includes

• 77 data tables and 68 additional tables
• Overview of the global intravenous (IV) therapy and vein access market
• Analyses of global market trends, with revenue data for 2023-2025, estimates for 2026, and projections of CAGRs through 2031
• Evaluation of the market by product type, application, and region
• Discussion of major market drivers, restraints, challenges, and opportunities shaping the adoption of IV therapy and vein access technologies worldwide
• Review of regulatory frameworks in key countries, along with analysis of macroeconomic factors, Porter's Five Forces, and the impact of U.S. tariffs on the industry
• Regional market coverage North America, Europe, Asia-Pacific, the Middle East & Africa, and South America
• Profiles of leading companies and emerging startups, highlighting their product offerings, business strategies, and recent developments, including BD, Fresenius SE & Co. KGaA, Baxter, B. Braun SE, and Insulet Corp.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Intravenous Therapy Overview
• Human Circulatory System
• Definition of Infusion Therapy
• Definition of Intravenous Therapy
• Types of IV Infusion
• Continuous Infusion
• Intermittent Infusion
• Patient-Controlled Infusion
• Methods of IV Infusion Pump
• Pump Infusion
• Drip Infusion
• IV Solutions
• General IV Solutions
• Parenteral Nutrition IV Solutions
• Premixed Drug IV Solutions
• IV Infusion Pumps
• Venous Access Devices (IV Catheters)
• Porter's Five Forces Analysis of the IV Therapy and Vein Access Market
• Competitive Rivalry (High)
• Threat of New Entrants (Moderate)
• Threat of Substitutes (Low)
• Bargaining Power of Buyers (High)
• Bargaining Power of Suppliers (Moderate)
• Macroeconomic Factors Analysis
• Inflation and Rising Manufacturing Costs
• Impact of the U.S.-Israel-Iran Conflict on the Intravenous Therapy and Vein Access Devices Market
• Slower Global Economic Growth and Capital Spending
• Government Healthcare Spending and Medical Device Localization

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Increasing Burden of Chronic Diseases Requiring Long-Term Infusion Therapy
• Growing Surgical Procedures and Hospital Admissions Driving Vascular Access Demand
• Rapid Expansion of Home Infusion Therapy
• Stronger Infection Prevention Guidelines Accelerating Adoption of Advanced Vein Access Technologies
• Rising Global Burden of VTE and Hospital-Acquired Infections Driving Demand for Advanced IV Therapy and Vein Access Solutions
• Expanding Global Geriatric Population
• Market Restraints
• Risk of Infections and Complications
• Regulatory Challenges in IV Therapy and Vein Access Market
• Safety and Recall Challenges in IV Therapy
• Reimbursement Policies
• Market Opportunities
• Technological Advances
• Expanding Pipeline of Infusion-Based Biologics and Specialty Therapies

Chapter 4 Regulatory Landscape

• Regulatory Scenario
• U.S.
• Europe
• Japan
• India
• China
• U.K.

Chapter 5 Emerging Trends and Technologies

• Key Takeaways
• Advances in Intraosseous Infusion Systems for Vascular Access
• Antimicrobial-Coated Sets
• Needleless Connectors
• IV Filters
• Smart Vein Visualization and Access Devices
• Smart IV Devices
• Blood Transfusion Sets
• Wireless Sensor Networks (WSN) and AI in IV Therapy
• Recent Advances in Intravenous Therapy and Vein Access
• Patent Analysis
• Key Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• IV Solutions and Sets
• Infusion Pumps and Accessories
• Vein Access Devices (IV Catheters)
• Market Analysis by Application
• Key Takeaways
• Hospitals
• Alternative Sites
• Home-Based
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Landscape

• Key Takeaways
• Industry Scenario
• Global Market Shares of Leading Companies
• Acquisitions
• Strategic Alliances

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ANGIODYNAMICS
• BAXTER
• B. BRAUN SE
• BD
• CARDINAL HEALTH
• COOK MEDICAL INC.
• FRESENIUS SE & CO. KGAA
• ICU MEDICAL INC.
• INSULET CORP.
• IRADIMED CORP.
• MEDTRONIC
• PFIZER INC.
• TERUMO CORP.
• VYGON
• WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.
• Few Emerging Startups/Market Disruptors

List of Tables

• Summary Table : Global Market for Intravenous Therapy and Vein Access, by Region, Through 2031
• Table 1 : Common Examples of General IV Solutions
• Table 2 : Porter's Five Forces Analysis: Overview
• Table 3 : Distribution of Vascular Access Devices Used in Home Infusion Therapy
• Table 4 : Number and Proportion of Persons Aged 65 Years and Over, by Development Group, 2023 and 2050
• Table 5 : Major Recalled Products in 2023, FDA
• Table 6 : Global Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 7 : Global Market for IV Solutions and Sets, by Region, Through 2031
• Table 8 : Global Market for IV Solutions and Sets, by Type, Through 2031
• Table 9 : Leading Manufacturers/Suppliers of General IV Solutions, 2025
• Table 10 : Global Market for General IV Solutions, by Region, Through 2031
• Table 11 : Leading Manufacturers/Suppliers of Parenteral Nutrition IV Solutions, 2025
• Table 12 : Global Market for Parenteral Nutrition IV Solutions, by Region, Through 2031
• Table 13 : Leading Manufacturers/Suppliers of Premixed Drug IV Solutions, 2025
• Table 14 : Global Market for Premixed Drug IV Solutions, by Region, Through 2031
• Table 15 : Global Market for Other IV Solutions and Sets, by Region, Through 2031
• Table 16 : Global Market for Infusion Pumps and Accessories, by Region, Through 2031
• Table 17 : Global Market for Infusion Pumps and Accessories, by Type, Through 2031
• Table 18 : Leading Manufacturers/Suppliers of Ambulatory/Disposable Infusion Pumps, 2025
• Table 19 : Leading Manufacturers/Suppliers of Insulin Infusion Pumps, 2025
• Table 20 : Leading Manufacturers/Suppliers of PCA Infusion Pumps, 2025
• Table 21 : Leading Manufacturers/Suppliers of Enteral Feeding Pumps, 2025
• Table 22 : Leading Manufacturers/Suppliers of Implantable Infusion Pumps, 2025
• Table 23 : Global Market for Specialized Infusion Pumps, by Region, Through 2031
• Table 24 : Global Market for Specialized Infusion Pumps, by Type, Through 2031
• Table 25 : Global Market for Other Infusion Accessories, by Region, Through 2031
• Table 26 : Leading Manufacturers/Suppliers of Large Volume Infusion Pumps, 2025
• Table 27 : Leading Manufacturers/Suppliers of Syringe Infusion Pumps, 2025
• Table 28 : Global Market for General Infusion Pumps, by Region, Through 2031
• Table 29 : Global Market for General Infusion Pumps, by Type, Through 2031
• Table 30 : Global Market for Vein Access Devices (IV Catheters), by Region, Through 2031
• Table 31 : Global Market for Vein Access Devices (IV Catheters), by Type, Through 2031
• Table 32 : Leading Manufacturers/Suppliers of Peripheral IV Catheters, 2025
• Table 33 : Global Market for Peripheral IV Catheters, by Region, Through 2031
• Table 34 : Leading Manufacturers/Suppliers of Central Venous Catheters (CVC), 2025
• Table 35 : Global Market for Central Venous Catheters (CVCS) , by Region, Through 2031
• Table 36 : Global Market for IV Therapy and Vein Access, by Application, Through 2031
• Table 37 : Global Market for IV Therapy and Vein Access in Hospitals, by Region, Through 2031
• Table 38 : Barriers and Facilitators to the Uptake of IV Therapies in Ambulatory Patients, 2024
• Table 39 : Global Market for IV Therapy and Vein Access in Alternative Sites, by Region, Through 2031
• Table 40 : Global Market for IV Therapy and Vein Access in Home-Based Care, by Region, Through 2031
• Table 41 : Global Market for IV Therapy and Vein Access, by Region, Through 2031
• Table 42 : North American Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 43 : North American Market for IV Solutions and Sets, by Type, Through 2031
• Table 44 : North American Market for Infusion Pumps and Accessories, by Type, Through 2031
• Table 45 : North American Market for Vein Access Devices (IV Catheters), by Type, Through 2031
• Table 46 : North American Market for IV Therapy and Vein Access, by Application, Through 2031
• Table 47 : North American Market for IV Therapy and Vein Access, by Country, Through 2031
• Table 48 : U.S. Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 49 : Canadian Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 50 : Mexican Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 51 : European Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 52 : European Market for IV Solutions and Sets, by Type, Through 2031
• Table 53 : European Market for Infusion Pumps and Accessories, by Type, Through 2031
• Table 54 : European Market for Vein Access Devices (IV Catheters), by Type, Through 2031
• Table 55 : European Market for IV Therapy and Vein Access, by Application, Through 2031
• Table 56 : European Market for IV Therapy and Vein Access, by Country, Through 2031
• Table 57 : German Market for IV Therapy and Vein Access, by Product Type, Through 2029
• Table 58 : U.K. Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 59 : French Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 60 : Italian Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 61 : Spanish Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 62 : Rest of the Europe Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 63 : Asia-Pacific Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 64 : Asia-Pacific Market for IV Solutions and Sets, by Type, Through 2031
• Table 65 : Asia-Pacific Market for Infusion Pumps and Accessories, by Type, Through 2031
• Table 66 : Asia-Pacific Market for Vein Access Devices (IV Catheters), by Type, Through 2031
• Table 67 : Asia-Pacific Market for IV Therapy and Vein Access, by Application, Through 2031
• Table 68 : Asia-Pacific Market for IV Therapy and Vein Access, by Country, Through 2031
• Table 69 : Chinese Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 70 : Indian Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 71 : Japanese Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 72 : South Korean Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 73 : Approved Substitute Overseas-Registered IV Fluids Under Section 19A of the Therapeutic Goods Act 1989 for 2025
• Table 74 : Australian Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 75 : Rest of Asia-Pacific Market for IV Therapy and Vein Access, by Product Type, Through 2029
• Table 76 : RoW Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 77 : RoW Market for IV Solutions and Sets, by Type, Through 2031
• Table 78 : RoW Market for Infusion Pumps and Accessories, by Type, Through 2031
• Table 79 : RoW Market for Vein Access Devices (IV Catheters), by Type, Through 2031
• Table 80 : RoW Market for IV Therapy and Vein Access, by Application, Through 2031
• Table 81 : RoW Market for IV Therapy and Vein Access, by Sub-Region, Through 2031
• Table 82 : South American Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 83 : MEA Market for IV Therapy and Vein Access, by Product Type, Through 2031
• Table 84 : Leading Manufacturers in the IV Therapy and Vein Access Market, 2025
• Table 85 : Acquisitions in IV Therapy and Vein Access Market, 2022-2025
• Table 86 : Major Strategic Alliances in the Intravenous Therapy and Vein Access Market, 2023-2026
• Table 87 : Information Sources in This Report
• Table 88 : Abbreviations Used in This Report
• Table 89 : AngioDynamics: Company Snapshot
• Table 90 : AngioDynamics: Financial Performance, FY 2024 and 2025
• Table 91 : AngioDynamics: Product Portfolio
• Table 92 : AngioDynamics: News/Key Developments, 2023-2024
• Table 93 : Baxter: Company Snapshot
• Table 94 : Baxter: Financial Performance, FY 2024 and 2025
• Table 95 : Baxter: Product Portfolio
• Table 96 : Baxter: News/Key Developments, 2024-2026
• Table 97 : B. Braun SE: Company Snapshot
• Table 98 : B. Braun SE: Financial Performance, FY 2024 and 2025
• Table 99 : B. Braun SE: Product Portfolio
• Table 100 : B. Braun SE: News/Key Developments, 2023-2026
• Table 101 : BD: Company Snapshot
• Table 102 : BD: Financial Performance, FY 2024 and 2025
• Table 103 : BD: Product portfolio
• Table 104 : BD: News/Key Developments, 2023-2025
• Table 105 : Cardinal Health: Company Snapshot
• Table 106 : Cardinal Health: Financial Performance, FY 2023 and 2024
• Table 107 : Cardinal Health: Product Portfolio
• Table 108 : Cardinal Health: News/Key Developments, 2024-2025
• Table 109 : Cook Medical Inc.: Company Snapshot
• Table 110 : Cook Medical Inc.: Product Portfolio
• Table 111 : Cook Medical Inc.: News/Key Developments, 2024
• Table 112 : Fresenius SE & Co. KGaA: Company Snapshot
• Table 113 : Fresenius SE & Co. KGaA: Financial Performance, FY 2024 and 2025
• Table 114 : Fresenius SE & Co. KGaA: Product Portfolio
• Table 115 : Fresenius SE & Co. KGaA: News/Key Developments, 2023-2026
• Table 116 : ICU Medical Inc.: Company Snapshot
• Table 117 : ICU Medical Inc.: Financial Performance, FY 2024 and 2025
• Table 118 : ICU Medical Inc.: Product Portfolio
• Table 119 : ICU Medical Inc.: News/Key Developments, 2023-2024
• Table 120 : Insulet Corp.: Company Snapshot
• Table 121 : Insulet Corp.: Financial Performance, FY 2024 and 2025
• Table 122 : Insulet Corp.: Product Portfolio
• Table 123 : Insulet Corp.: News/Key Developments, 2023-2025
• Table 124 : IRadimed Corp.: Company Snapshot
• Table 125 : IRadimed Corp.: Financial Performance, FY 2024 and 2025
• Table 126 : IRadimed Corp.: Product Portfolio
• Table 127 : IRadimed Corp.: News/Key Developments, 2023-2025
• Table 128 : Medtronic: Company Snapshot
• Table 129 : Medtronic: Financial Performance, FY 2024 and 2025
• Table 130 : Medtronic: Product Portfolio
• Table 131 : Medtronic: News/Key Developments, 2023-2025
• Table 132 : Pfizer Inc.: Company Snapshot
• Table 133 : Pfizer Inc.: Financial Performance, FY 2024 and 2025
• Table 134 : Pfizer Inc.: Product Portfolio
• Table 135 : Pfizer Inc.: News/Key Developments, 2023-2024
• Table 136 : Terumo Corp.: Company Snapshot
• Table 137 : Terumo Corp.: Financial Performance, FY 2024 and 2025
• Table 138 : Terumo Corp.: Product Portfolio
• Table 139 : Terumo Corp.: News/Key Developments, 2023-2025
• Table 140 : Vygon: Company Snapshot
• Table 141 : Vygon: Product Portfolio
• Table 142 : Wellmed International Industries Pvt. Ltd.: Company Snapshot
• Table 143 : Wellmed International Industries Pvt. Ltd.: Product Portfolio
• Table 144 : List of a Few Emerging Startups/Market Disruptors

List of Figures

• Summary Figure : Global Market Shares for Intravenous Therapy and Vein Access, by Region, 2025
• Figure 1 : Porter's Five Forces Analysis: Global IV Therapy and Vein Access Market
• Figure 2 : Market Dynamics of IV Therapy and Vein Access
• Figure 3 : Patents Documented, by Top Owners, January 2025 to June 2026
• Figure 4 : Documented Patent Shares, by Jurisdiction, January 2025 to June 2026
• Figure 5 : Patent Shares for Surgical Devices, by Type, January 2025 to June 2026
• Figure 6 : Global Market Shares for IV Therapy and Vein Access, by Product Type, 2025
• Figure 7 : Global Market Shares for IV Solutions and Sets, by Type, 2025
• Figure 8 : Global Market Shares for Infusion Pumps and Accessories, by Type, 2025
• Figure 9 : Global Market Shares for Vein Access Devices (IV Catheters), by Type, 2025
• Figure 10 : Global Market Shares for IV Therapy and Vein Access, by Application, 2025
• Figure 11 : Global Market Shares for IV Therapy and Vein Access, by Region, 2025
• Figure 12 : Global Market Shares for IV Therapy and Vein Access, by Leading Companies, 2025
• Figure 13 : AngioDynamics: Revenue Shares, by Business Unit, FY 2025
• Figure 14 : AngioDynamics: Revenue Shares, by Country/Region, FY 2025
• Figure 15 : Baxter: Revenue Shares, by Business Unit, FY 2025
• Figure 16 : Baxter: Revenue Shares, by Country/Region, FY 2025
• Figure 17 : B. Braun SE: Revenue Shares, by Business Unit, FY 2025
• Figure 18 : B. Braun SE: Revenue Shares, by Country/Region, FY 2025
• Figure 19 : BD: Revenue Shares, by Business Unit, FY 2025
• Figure 20 : BD: Revenue Shares, by Country/Region, FY 2025
• Figure 21 : Cardinal Health: Revenue Shares, by Business Unit, FY 2024
• Figure 22 : Cardinal Health: Revenue Shares, by Country/Region, FY 2024
• Figure 23 : Fresenius SE & Co. KGaA: Revenue Shares, by Business Unit, FY 2025
• Figure 24 : Fresenius SE & Co. KGaA: Revenue Shares, by Country/Region, FY 2025
• Figure 25 : ICU Medical Inc.: Revenue Shares, by Business Unit, FY 2025
• Figure 26 : ICU Medical Inc.: Revenue Shares, by Country/Region, FY 2025
• Figure 27 : Insulet Corp.: Revenue Shares, by Business Unit, FY 2025
• Figure 28 : Insulet Corp.: Revenue Shares, by Country/Region, FY 2025
• Figure 29 : IRadimed Corp.: Revenue Shares, by Business Unit, FY 2025
• Figure 30 : IRadimed Corp.: Revenue Shares, by Country/Region, FY 2025
• Figure 31 : Medtronic: Revenue Shares, by Business Unit, FY 2024
• Figure 32 : Medtronic: Revenue Shares, by Country/Region, FY 2024
• Figure 33 : Pfizer Inc.: Revenue Shares, by Business Unit, FY 2025
• Figure 34 : Pfizer Inc.: Revenue Shares, by Country/Region, FY 2025
• Figure 35 : Terumo Corp.: Revenue Shares, by Business Unit, FY 2025
• Figure 36 : Terumo Corp.: Revenue Shares, by Country/Region, FY 2025